Clinical Trial Update: Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study. [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled study evaluating treatment for low IGF-1 syndrome in chronic heart failure has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Federico II University | Conditions: Chronic Heart Failure | Phase 2 | Status: SUSPENDED